The skill of surgery has progressed over the years. Suture like threads produced from a wide-range of substances were used prior as a mechanical closure for the wounds. Surgical adhesives and hemostats consist of five new families, which consist of fibrin glue, cyanoacrylate, polyethylene glycol polymer, albumin cross linked with glutaraldehyde and bovine collagen and thrombin. Now in the last 30 years, fibrin glue has beenused in various indications throughout all surgical fields.
Fibrin glue is a derivative of human blood products andanimaland it is mostly withdrawn from collective plasma and comprises of different quantities of purified and virally inactivated human proteins. Biological fibrin glue typically contains two basic components such as human thrombin and human fibrinogen, together with a fibrinolysis inhibitor to prevent fibrin degradation during the storage. The various features of fibrin glue are high surface adherence strength, high internal bond strength and capability to improve tissue regeneration and clot formation. Fibrin glue is primarily used inhemostasis, but it isalso used to heal the wounds and as biological sealants,it in different situations such as air, gastrointestinal, bile and lymphatic leaks on a larger scale. Fibrin glue reducesthe threat of infection, offersquick hemostasis on the treated part, and improves cosmesis. Fibrin glue permits the surgeon to execute the operation using minor incision and with reduced tissue trauma.
It also encourages natural tissue healing. On the other hand, one of the drawback of fibrin glue is the risk of passing on of infectious organisms from human bodies to the glue. Additionally, their role in tissue engineering is recently under investigation. Recently fibrin glue has received approval from U.S. FDA and European Union for their use in spleen trauma, cardiovascular surgery and for the closure of colostomies. Tisseel, biocol, and beriplast are some of the commercially prepared fibrin sealants.
The global fibrin glue market is segmented based on application and geography. The applications of fibrin glue arein cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery,general surgery and wound management. The burn bleeding and cardiac surgeriessegment dominates the fibrin glue market in applications category.
Based on the geography, market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the market due to higher ageing population and increasing number of surgical procedures whereas, developing countries such as India and China are expected to be fastest growing in the fibrin glue market due to high spending in health expenditure and increase in the government funding.
In the recent years, the usage of fibrin glue has risen due to the factors such as increasing number of surgical procedures, rising incidences of complications such as diabetic ulcers, pressure sores chronic wounds etc. increase spending on health expenditure and increase in the ageing population. All these factors are responsible to drive the fibrin glue market. Government funding and technological advancement are known to create an opportunities for fibrin glue market.However,the rise in the minimum invasive procedures such as endoscopic and laparoscopic surgeries can hinder the growth of fibrin glue market.
Some of the key players of fibrin glue market areHaemcure Corporation, Baxter International Inc., Omrix Biopharmaceutical, Inc., Vivostat A/S, CSL Behring, CryolifeInc.and Interpore Cross.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Fibrin Glue Market during 2016- 2023
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453